Is Organovo efficiently growing its dividend?
Organovo does not have a long track record of dividend growth. In the past three months, Organovo insiders have not sold or bought any company stock. Only 2.00% of the stock of Organovo is held by insiders. Only 26.29% of the stock of Organovo is held by institutions.
How much is an ONVO stock worth?
One share of ONVO stock can currently be purchased for approximately $3.90. How much money does Organovo make? Organovo has a market capitalization of $33.95 million and generates $2.20 million in revenue each year. The medical research company earns $-16.83 million in net income (profit) each year or ($1.36) on an earnings per share basis.
What happened to Organovo Holdings Inc (ONVO)?
Catherine Wood ( Trades , Portfolio )'s ARK Investment Management has revealed a large reduction in the Organovo Holdings Inc. (NASDAQ:ONVO) position alongside a small reduction in the Syros Pharmaceuti... Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONF...
What is the PE (price targets) ratio of Organovo?
Only 26.29% of the stock of Organovo is held by institutions. The P/E ratio of Organovo is -2.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
How has Organovo's stock price performed in 2022?
Organovo's stock was trading at $3.63 on January 1st, 2022. Since then, ONVO shares have decreased by 42.4% and is now trading at $2.09. View the...
When is Organovo's next earnings date?
Organovo is scheduled to release its next quarterly earnings announcement on Tuesday, June 21st 2022. View our earnings forecast for Organovo .
How were Organovo's earnings last quarter?
Organovo Holdings, Inc. (NASDAQ:ONVO) released its quarterly earnings data on Thursday, August, 8th. The medical research company reported ($1.00)...
When did Organovo's stock split? How did Organovo's stock split work?
Shares of Organovo reverse split on the morning of Wednesday, August 19th 2020. The 1-20 reverse split was announced on Monday, August 17th 2020. T...
Who are Organovo's key executives?
Organovo's management team includes the following people: Mr. Keith E. Murphy , Exec. Chairman & Principal Exec. Officer (Age 50, Pay $397.18k)...
What is Taylor Crouch's approval rating as Organovo's CEO?
3 employees have rated Organovo CEO Taylor Crouch on Glassdoor.com . Taylor Crouch has an approval rating of 38% among Organovo's employees. This...
Who are some of Organovo's key competitors?
Some companies that are related to Organovo include Orchard Therapeutics (ORTX) , Brookline Capital Acquisition (BCAC) , SAB Biotherapeutics (SA...
What other stocks do shareholders of Organovo own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Organovo investors own include Brainstorm Cell Therapeutic...
What is Organovo's stock symbol?
Organovo trades on the NASDAQ under the ticker symbol "ONVO."
What is Organovo Holdings?
What is the symbol for Organovo?
Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded in April 2007 and is headquartered in Solana Beach, CA.
What is the P/E ratio of Organovo?
Organovo trades on the NASDAQ under the ticker symbol "ONVO."
When will Organovo reverse split?
The P/E ratio of Organovo is -4.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Does Organovo pay dividends?
Shares of Organovo reverse split on Wednesday, August 19th 2020. The 1-20 reverse split was announced on Monday, August 17th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, August 18th 2020. An investor that had 100 shares of Organovo stock prior to the reverse split would have 5 shares after the split.
Is Organovo a company?
Organovo does not currently pay a dividend.
Will Organovo Continue to Surge Higher?
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (“Organovo” or the “Company”) (Nasdaq: ONVO) announced today that it has regained compliance with the minimum bid price requiremen...
How many articles has The Fool written on Organovo?
As of late, it has definitely been a great time to be an investor in Organovo.
What is governance score?
The Fool has written over 200 articles on Organovo Holdings.
What is the environmental score?
The governance score is comprised of weighted key performance indicators related to leadership, management, and business model.
Who owns restricted shares of a company?
The environmental score is comprised of weighted key performance indicators related to natural capital, innovation, and climate change.
What is dividend percentage?
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
